ATE428444T1 - Zusammensetzungen zur vorbeugung und zur behandlung digestiver erkrankungen - Google Patents

Zusammensetzungen zur vorbeugung und zur behandlung digestiver erkrankungen

Info

Publication number
ATE428444T1
ATE428444T1 AT01904557T AT01904557T ATE428444T1 AT E428444 T1 ATE428444 T1 AT E428444T1 AT 01904557 T AT01904557 T AT 01904557T AT 01904557 T AT01904557 T AT 01904557T AT E428444 T1 ATE428444 T1 AT E428444T1
Authority
AT
Austria
Prior art keywords
digestive organs
action
digestive
prevention
compositions
Prior art date
Application number
AT01904557T
Other languages
English (en)
Inventor
Hiromasa Araki
Atsufumi Kawabata
Ryotaro Kuroda
Kazuaki Kakehi
Shuichi Tanaka
Kenzo Kawai
Sachiyo Nishimura
Hiroyuki Nishikawa
Original Assignee
Fuso Pharmaceutical Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fuso Pharmaceutical Ind filed Critical Fuso Pharmaceutical Ind
Application granted granted Critical
Publication of ATE428444T1 publication Critical patent/ATE428444T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4826—Trypsin (3.4.21.4) Chymotrypsin (3.4.21.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
AT01904557T 2000-02-24 2001-02-20 Zusammensetzungen zur vorbeugung und zur behandlung digestiver erkrankungen ATE428444T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000047515A JP4065642B2 (ja) 2000-02-24 2000-02-24 消化器系疾患の予防、治療用組成物
PCT/JP2001/001188 WO2001062291A1 (en) 2000-02-24 2001-02-20 Compositions for preventing and treating digestive diseases

Publications (1)

Publication Number Publication Date
ATE428444T1 true ATE428444T1 (de) 2009-05-15

Family

ID=18569755

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01904557T ATE428444T1 (de) 2000-02-24 2001-02-20 Zusammensetzungen zur vorbeugung und zur behandlung digestiver erkrankungen

Country Status (8)

Country Link
US (2) US20030166553A1 (de)
EP (1) EP1258251B1 (de)
JP (1) JP4065642B2 (de)
AT (1) ATE428444T1 (de)
AU (2) AU2001232345B2 (de)
CA (1) CA2400650C (de)
DE (1) DE60138366D1 (de)
WO (1) WO2001062291A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6346510B1 (en) 1995-10-23 2002-02-12 The Children's Medical Center Corporation Therapeutic antiangiogenic endostatin compositions
GB0213286D0 (en) 2002-06-10 2002-07-24 Univ Edinburgh Par-2-Activating peptide derivative and pharmaceutical composition using the same
WO2005032554A1 (en) 2003-10-03 2005-04-14 Astron Research Pvt. Ltd A novel transmucosal delivery system
JP4653516B2 (ja) * 2004-02-27 2011-03-16 扶桑薬品工業株式会社 涙液分泌促進ペプチドおよびその組成物
US20060063930A1 (en) * 2004-08-20 2006-03-23 Agoston Gregory E Compositions and methods comprising proteinase activated receptor antagonists
US8268789B2 (en) 2004-09-30 2012-09-18 Kowa Company, Ltd. PAR-2 antagonists
EP1845104A4 (de) 2004-12-28 2009-08-05 Kowa Co Par-ii-agonist
US8133864B2 (en) 2005-03-29 2012-03-13 Kowa Company, Ltd. PAR-2 agonist
GB2450747A (en) * 2007-07-06 2009-01-07 Univ Sheffield Treatment of sensorineural hearing loss

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4766569A (en) * 1985-03-04 1988-08-23 Lattice Semiconductor Corporation Programmable logic array
US5541116A (en) * 1991-09-30 1996-07-30 B.R.A.H.M.S. Diagnostica Gmbh Method for the stabilization of endogenous, physiologically active peptides
US5517627A (en) * 1992-09-18 1996-05-14 3Com Corporation Read and write data aligner and method
US5619665A (en) * 1995-04-13 1997-04-08 Intrnational Business Machines Corporation Method and apparatus for the transparent emulation of an existing instruction-set architecture by an arbitrary underlying instruction-set architecture
US5636224A (en) * 1995-04-28 1997-06-03 Motorola Inc. Method and apparatus for interleave/de-interleave addressing in data communication circuits
JPH11171791A (ja) * 1997-10-07 1999-06-29 Kanegafuchi Chem Ind Co Ltd 蛋白質分解酵素を含むヘリコバクター属細菌の除菌剤及び／又は殺菌剤、並びに該細菌に起因する疾患の治療剤及び／又は発症抑制剤
US6963962B2 (en) * 2002-04-11 2005-11-08 Analog Devices, Inc. Memory system for supporting multiple parallel accesses at very high frequencies

Also Published As

Publication number Publication date
CA2400650C (en) 2010-10-19
WO2001062291A1 (en) 2001-08-30
CA2400650A1 (en) 2001-08-30
AU3234501A (en) 2001-09-03
EP1258251A1 (de) 2002-11-20
AU2001232345B2 (en) 2004-09-23
DE60138366D1 (de) 2009-05-28
JP2001233790A (ja) 2001-08-28
EP1258251A4 (de) 2003-04-09
EP1258251B1 (de) 2009-04-15
US20030166553A1 (en) 2003-09-04
JP4065642B2 (ja) 2008-03-26
US7550437B2 (en) 2009-06-23
US20060172949A1 (en) 2006-08-03

Similar Documents

Publication Publication Date Title
BR9909996A (pt) Composto, produtos, processo para a preparação de um composto, formulação farmacêutica, uso de um composto, e, processos para inibir secreção de ácido gástrico, para o tratamento de doenças inflamatórias gastrointestinais, e para o tratamento ou profilaxia de condições que envolvem infecção da mucosa gástrica humana por helicobacter pylori
GB0009056D0 (en) Composition comprising free amino acids
CA2341031A1 (en) Novel salt form of pantoprazole
DE60138366D1 (de) Zusammensetzungen zur vorbeugung und zur behandlung digestiver erkrankungen
BR9913103A (pt) Composto, processo para a preparação do mesmo, formulação farmacêutica, uso do composto, processos para inibir a secreção do ácido gástrico, para o tratamento de doenças inflamatórias gastrointestinal, e para o tratamento ou profilaxia de condições que envolvem a infeção por helicobacter pylori da mucosa gástrica humana, e, formulações farmacêuticas para o uso na inibição da secreção de ácido gástrico, para o uso no tratamento de doenças inflamatórias gastrointestinais, e para o uso no tratamento ou profilaxia de condições que envolvem a infecção por helicobacter pylori da mucosa gástrica humana
BR0015698A (pt) Composições e métodos para tratamento de doenças alérgicas
ATE263572T1 (de) Verwendung von gastrin fragmenten oder sythetischen analogen von gastrin zur herstellung eines arzneimittels zur behandlung der helicobacter pylori assozierten störungen
RU2009127750A (ru) Препарат против helicobacter pylori, ингибирующий секрецию желудочного сока
RU2001107149A (ru) Тауролидин и/или таурултам против инфекционной язвенной болезни или инфекционного гастрита
BR0211846A (pt) Composto, processo para a preparação do mesmo, formulação farmacêutica, uso de um composto, e, métodos para inibir a secreção de ácido gástrico, para tratar doenças gastrintestinais inflamatórias, e para tratar ou profilaxia de condições envolvendo infecção por helicobacter pylori de mucosa gástrica humana
MY126117A (en) Pharmaceutical compositions
GR3019917T3 (en) Benzimidazole derivatives as antimicrobal agent against campylobacter pylon
KR910700059A (ko) 위장관의 장해 약제치료용 디메틸폴리실옥산사용
Borkent et al. Treatment of ulcerative reflux oesophagitis with colloidal bismuth subcitrate in combination with cimetidine.
IL159241A0 (en) Use of branched-chain fatty acids and derivatives thereof for the treatment of pain
IL156169A0 (en) Use of 6-dimethylaminomethyl-1-phenylcyclohexane compounds for treating urinary incontinence
ATE332697T1 (de) Cyanidinmischung zur behandlung von dickdarmkrebs
NO910033L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 2-hydroksy-3-fenoksypropylaminoforbindelser.
EP0992241A4 (de) Medizinische zusammensetzungen gegen helicobacter pylori
BR9406772A (pt) Composto composicão farmacêutica uso do composto processos para preparação do composto para inibição de secreção de acido gastrico para o tratamento de doenças infamatorias gastrointestinais para o tratamento ou profilaxia de condições infecção por helicobacter pylori de mucosa gastrica humana e formulação farmacêutica
RU1635329C (ru) Средство для уничтожения пилорических кампилобактеров и способ санации слизистой оболочки желудка
Abou Bakr et al. Outcome of duodenal switch procedure for treatment of duodenogastric reflux
LEE et al. Laparoscopic Treatment of Duodenal Ulcers: A vagotomy assessed by the congo red test
UA43128A (uk) Спосіб профілактики післяопераційних ускладнень рецидивних вентральних гриж
RU97111830A (ru) Соединения для ингибирования секреции желудочной кислоты

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties